1. Effect of Ramipril vs Amlodipine on Renal Outcomes in Hypertensive Nephrosclerosis: A Randomized Controlled Trial
- Author
-
Agodoa, Lawrence Y., Appel, Lawrence, Bakris, George L., Beck, Gerald, Bourgoignie, Jacques, Briggs, Josephine P., Charleston, Jeanne, Cheek, DeAnna, Cleveland, William, Douglas, Janice G., Douglas, Margaret, Dowie, Donna, Faulkner, Marquetta, Gabriel, Avril, Cassman, Jennifer, Greene, Tom, Hall, Yvette, Hebert, Lee, Hiremath, Leena, Jamerson, Kenneth, Johnson, Carolyn J., Kopple, Joel, Kusek, John, Lash, James, Lea, Janice, Lewis, Julia B., Lipkowitz, Michael, Massry, Shaul, Middleton, John, Miller III, Edgar R., Norris, Keith, O'Connor, Daniel, Ojo, Akinlou, Phillips, Robert A., Pogue, Velvie, Rahman, Mahboob, Randall, Otelio S., Rostand, Stephen, Schulman, Gerald, Smith, Winifred, Thornley-Brown, Denyse, Tisher, C. Craig, Toto, Robert D., and Wright, Jr., Jackson T.
- Subjects
Ramipril -- Evaluation ,Kidney diseases -- Development and progression ,Hypertension -- Complications ,African Americans -- Diseases - Abstract
The ACE inhibitor ramipril may slow the progression of kidney disease in African-Americans who have hypertension. This was the conclusion of a study of 1,094 African-Americans who had hypertensive kidney disease.
- Published
- 2001